Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Brain Protein May Be Early Indicator of Alzheimer’s Disease

By LabMedica International staff writers
Posted on 08 Feb 2012
Recent research has shown that specific proteins found in exosomes may be indicators of advanced Alzheimer’s disease (AD).

The scientists discovered that exosomes containing tau and other proteins are an indicator of AD. More...
Exosomes can be found in the cerebral spinal column and examined through a spinal tap. High levels of tau found in the exosome are an indicator of advanced stages of AD.

The researchers from MassBay Community College (Wellesley Hills, MA, USA) successfully collaborated with biologic science counterparts from University of Massachusetts (UM)-Lowell (MA, USA) and Boston University (MA, USA) on experiments related to early detection of AD. The research was performed in MassBay’s biotechnology and environmental science labs.

According to Dr. Sudad Saman, an adjunct professor of STEM at MassBay, and researcher and author of the article, stated, “Often Alzheimer’s disease is detected in patients in its later stages, when the disease has become more apparent to loved ones. By discovering Alzheimer’s in patients earlier, they can start taking medications, even five years earlier can be beneficial to extending the life of the individual as well as delaying the degenerating effects of the disease.”

“This is extraordinary work being done here at MassBay,” said President John O'Donnell. “MassBay has long benefitted from world-class biotechnology and environmental science programs, and our elite professors continue to make important contributions to the world of science.”

“The result of our work may become revolutionary in diagnosing Alzheimer’s disease in its early onset,” concluded Dr. Sudad Saman. “We believe our discovery is quite significant.”

Related Links:

Boston University
MassBay Community College
University of Massachusetts-Lowell



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.